Table 1.
Time (min) | Number of cells with positive response change | Total number of cells | Wilcoxon signed-rank test |
---|---|---|---|
Combined SCT and skin burst protocol | |||
15–25 | 4 | 8 | 1 |
25–35 | 3 | 8 | 1 |
35–45 | 5 | 8 | 0.54 |
45–55 | 7 | 10 | 0.28 |
55–65 | 3 | 7 | 1 |
65–75 | 6 | 9 | 0.65 |
75–85 | 4 | 8 | 0.84 |
85–95 | 6 | 7 | 0.05 |
Skin burst and simultaneous single IO stimulation protocol | |||
5–15 | 2 | 6 | 0.84 |
15–25 | 3 | 5 | 0.63 |
25–35 | 3 | 5 | 0.43 |
35–45 | 3 | 5 | 0.63 |
Skin burst and delayed single IO stimulation protocol | |||
5–15 | 1 | 5 | 0.31 |
15–25 | 2 | 5 | 0.31 |
25–35 | 3 | 4 | 0.25 |
Wilcoxon signed-rank test gives the P value (rightmost column) for the null hypothesis that there is no potentiation. Note that in pure chance data, 1 out of the 20 P values is expected to fall within the 5% range, which is also the case here (1 out of the 15 comparisons made)